Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect Source: ERJ Open Res, 7 (1) 00011-2021; 10.1183/23120541.00011-2021 Year: 2021
AmbOx trial: does ambulatory oxygen improve quality of life in patients with fibrotic interstitial lung disease? Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Predictors of quality of life in patients with interstitial lung disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
Do causes influence clinical, functional and quality of life aspects on patients with bronchiectasis not associated with cystic fibrosis? Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019
Psychological predictors of health-related quality of life of interstitial lung disease patients. Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019
Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes Source: Eur Respir J, 55 (1) 1900647; 10.1183/13993003.00647-2019 Year: 2020
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019 Year: 2019
Quality of life and health status in interstitial lung diseases Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008
Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
Evaluation of lung function and health related quality of life in COPD patients via telemedicine Source: Eur Respir J 2003; 22: Suppl. 45, 243s Year: 2003
Increased self-management capacity leads to improved health outcomes for chronic lung disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005
Reducing exacerbations leads to a better health-related quality of life in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 238s Year: 2003
Interventions to improve symptom control and quality of life in patients with interstitial lung disease: a systematic review and meta-analysis Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018
The physical and psychological needs of patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019
The quality of life comparative research of sarcoidosis patients and patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 254s Year: 2003
Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes Source: Eur Respir J, 55 (4) 2000105; 10.1183/13993003.00105-2020 Year: 2020
How COPD patients understand their disease and what are their future expectations? Source: International Congress 2016 – Smoking-related diseases Year: 2016
From life threatening to chronic connective tissue disease-associated interstitial lung disease: all you need to know Source: Virtual Congress 2020 – From life threatening to chronic connective tissue disease-associated interstitial lung disease (CTD-ILD): all you need to know Year: 2020
Could a domiciliary chronic obstructive pulmonary disease care programme improve patients quality of life? Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004